Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue 3, 2012, Pages 403-408

  Smith, Valerie A ^a   MaDan, Olivia P ^a   Lentsch, Eric J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Head and neck cancer; Lip tumors; Merkel cell carcinoma; Scalp tumors; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; BONE TUMOR; CANCER INVASION; CANCER PROGNOSIS; CARTILAGE TUMOR; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EAR TUMOR; FACE TUMOR; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LIP TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; MUSCLE TUMOR; NECK TUMOR; REGIONAL METASTASIS; SCALP TUMOR; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEER PROGRAM; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84858810493     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811431789     Document Type: Article

References (21)

1. Pellitteri PK, Takes RP, Lewis JS, et al. Merkel cell carcinoma of the head and neck. Head Neck. 2011 Jun 20. [Epub ahead of print]. doi: 10.1002/hed.21787.
2. Lanoy E, Costagliola D, Engels EA. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer. 2010;126:1724-1731.
3. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana- Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142:685-690.
4. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010; 37:20-27.
5. Garbe C, Buttner P, Bertz J, et al. Primary cutaneous melanoma. Cancer. 1995;75:2492-2498.
6. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol. 2006;47:28-33.
7. Randle HW. Basal cell carcinoma: identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255-261. (Pubitemid 26088390)
8. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas: part 1: overview. J Dermatol Surg Oncol. 1991;17:713-718.
9. Golger A, Young DS, Ghazarian D, Neligan PC. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg. 2007;133:442-447. (Pubitemid 46799779)
10. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol. 2008;144:515-521. (Pubitemid 351581109)
11. Tseng WH, Martinez SR. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res. 2011;167:192-198.
12. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
13. National Cancer Institute. SEER Brochure. NIH Publication No. 05-4772. September 2005. http://www.seer.cancer.gov/about/SEER-brochure.pdf
14. Lemos BD, Storer BE, Iyer JG, et al. Pathologic node evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63:751-761.
15. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992; 26:976-990.
16. Veness MJ. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol. 2007;2007:80572.
17. Samarasinghe V, Madan V, Lear JT. Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther. 2011;11:763-769.
18. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamouscell carcinoma: a prospective study. Lancet Oncol. 2008;9: 713-720.
19. Mourouzis C, Boynton A, Grant J, et al. Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J Craniomaxillofac Surg. 2009;37:443-447.
20. Clark RR, Soutar DS. Lymph node metastases from auricular squamous cell carcinoma: a systematic review and meta-analysis. J Plast Reconstr Aesthetic Surg. 2008;61:1140-1147.
21. The National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Merkel cell carcinoma. Version 2.2011. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp